Sign up to The Irish Times Archive (1859 - 2008)My Account »

Thu 11 Nov 2002Elan to receive $100m for restructured deal with LigandElan is to receive a $100 million (€99 million) cash payment from San Diego-based pharmaceuticals group Ligand for restructuring its agreement with the company regarding Avinza, an oral form of morphine.In addition to the $100 million payment, Elan will receive $20 million from the sale of 2.2 million Ligand shares to the company at $9.00 per share, above the current market price.